Figure 5
SATB1 and p21 expression in CD30+LPD clinical samples. (A) Immunohistochemistry shows diffuse p21 expression in SATB1– PCALCLs (PCALCL-1), whereas in SATB1+ PCALCLs (PCALCL-2), p21+ cells were <20%. (B) Double staining on LyP samples shows that, among large atypical lymphocytes, SATB1 (red) and p21 (green) detect distinct populations of atypical cells. Only a small portion of SATB1– reactive lymphocytes was positive for p21 staining. DAPI (blue) was used to visualize cell nuclei.

SATB1 and p21 expression in CD30+LPD clinical samples. (A) Immunohistochemistry shows diffuse p21 expression in SATB1 PCALCLs (PCALCL-1), whereas in SATB1+ PCALCLs (PCALCL-2), p21+ cells were <20%. (B) Double staining on LyP samples shows that, among large atypical lymphocytes, SATB1 (red) and p21 (green) detect distinct populations of atypical cells. Only a small portion of SATB1 reactive lymphocytes was positive for p21 staining. DAPI (blue) was used to visualize cell nuclei.

Close Modal

or Create an Account

Close Modal
Close Modal